Stockreport

Wall Street Rallies Behind Lexeo Therapeutics (LXEO)'s Gene Therapy Pipeline [Yahoo! Finance]

Lexeo Therapeutics, Inc.  (LXEO) 
PDF a consensus buy from all eleven analysts covering the stock. While the target price ranges from $12 to $30, the median price target of $19 translates to an upside potent [Read more]